See all news

NIH Funding Opportunities and Notices for July 20, 2018 (The NIH Guide TOC)

Weekly NIH Funding Opportunities and Notices

NIH Guide for Grants and Contracts
July 20, 2018
Table of Contents (TOC)
Web Version

Notices

  • HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2019-1) Now Available
    (NOT-OD-18-209) Office of the Director, NIH
  • Updated Notice of NIH’s Interest in Diversity
    (NOT-OD-18-210) Office of the Director, NIH
  • NIH Implementation of the Burden-Reducing Provisions of the 2018 Common Rule
    (NOT-OD-18-211) Office of the Director, NIH
  • Delayed Enforcement and Short-Term Flexibilities for Some Requirements Affecting Prospective Basic Science Studies Involving Human Participants
    (NOT-OD-18-212) Office of the Director, NIH
  • Notice of Information: Initiative for Collaborative Research Between Investigators in the USA and in Norway
    (NOT-AI-18-049)
    National Institute of Allergy and Infectious Diseases
  • Notice of Intent to Publish a Funding Opportunity Announcement for NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp; Clinical Trial Optional)
    (NOT-AT-18-014)
    National Center for Complementary and Integrative Health
  • Notice of Change of Requirements for PAR-18-218, “Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)”
    (NOT-DA-18-018)
    National Institute on Drug Abuse
  • Notice of Change of Requirements for PAR-18-219, “Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)”
    (NOT-DA-18-019)
    National Institute on Drug Abuse
  • Notice of Intent to Publish a Funding Opportunity Announcement for Data Coordinating Center for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
    (NOT-DA-18-025)
    National Institute on Drug Abuse
  • Notice of Intent to Publish a Funding Opportunity Announcement for Research Site for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
    (NOT-DA-18-026)
    National Institute on Drug Abuse
  • Notice of Correction to Letter of Reference Receipt Date in RFA-DA-18-019 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
    (NOT-DA-18-028)
    National Institute on Drug Abuse
  • Notice of Early Application Receipt Date for PAR-18-854, Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
    (NOT-DK-18-019)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Behavioral and Social Science Research
    Office of Disease Prevention
  • Notice of Clarification for PAR-18-844-Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    (NOT-HG-18-010)
    National Human Genome Research Institute
  • Notice of Clarification to PAR-18-843: Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    (NOT-HG-18-011)
    National Human Genome Research Institute
  • Notice of Information: Change in Letter of Intent Due Dates for PAR-18-747 “Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)”
    (NOT-MD-18-007)
    National Institute on Minority Health and Health Disparities
  • Notice of Information: Change in Letter of Intent Due Dates for PAR-18-745 “Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)”
    (NOT-MD-18-008)
    National Institute on Minority Health and Health Disparities
    National Institute on Drug Abuse
  • Notice Regarding New Applications for PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
    (NOT-OH-18-010)
    National Institute for Occupational Safety and Health

Requests for Applications

  • Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
    (RFA-AR-19-013)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): April 9, 2019; January 9, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
  • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
    (RFA-HL-19-025)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 10, 2018, February 11, 2019, October 10, 2019, February 11, 2020, October 9, 2020, February 11, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
    (RFA-HL-19-026)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 10, 2018, February 11, 2019, October 10, 2019, February 11, 2020, October 9, 2020, February 11, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
    (RFA-MH-19-145)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 27, 2018 and September 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
    (RFA-MH-19-146)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 27, 2018 and September 6, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
    (RFA-MH-19-147)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 27, 2018; March 7, 2019; September 6, 2019; March 6, 2020; September 9, 2020; March 4, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
    (RFA-RM-18-021)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 26, 2018? by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

Program Announcements

  • Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
    (PA-18-856)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Minority Health and Health Disparities
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
    (PA-18-858)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply or Month(s) Day(s), Year(s), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
    (PA-18-859)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply or Month(s) Day(s), Year(s), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 – Clinical Trial Optional)
    (PA-18-861)
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 – Clinical Trial Optional)
    (PA-18-862)
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 – Clinical Trial Optional)
    (PA-18-863)
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
    (PAR-18-857)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Minority Health and Health Disparities
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply
  • Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
    (PAR-18-860)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): October 15, 2018, June 14, 2019, February 14, 2020, October 15, 2020 Applications due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
    (PAR-18-864)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
    (PAR-18-865)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt/Submission Date(s): October 4, 2018;July 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Categories: Uncategorized